Results 281 to 290 of about 286,999 (386)

A micropuncture study of collecting tubule function in rats with hereditary diabetes insipidus [PDF]

open access: bronze, 1971
Rex L. Jamison   +4 more
openalex   +1 more source

Randomized clinical trial evaluating kinetic benefits of desensitizing agents: Magnitude, onset, and stability of relief

open access: yesJournal of Periodontology, EarlyView.
Abstract Background Dentin hypersensitivity (DH) is common, particularly among periodontal patients. This trial evaluated magnitude of desensitizing benefit, onset of action, and complete relief of three dentifrices with distinct desensitizing technologies.
Aaron R. Biesbrock   +7 more
wiley   +1 more source

Tubulering

open access: yes, 1987
Tubulering kan vara ett sätt att öka dräneringseffektiviteten till en rimlig kostnad, speciellt på de mycket styva lerjordarna som p.g.a. låg genomsläpplighet är svårdränerade. Funktionstiden för en tubulering som utförs under goda förutsättningar är svår att förutsäga, men omkring 5 år kan anses normalt.
openaire   +1 more source

CONTRACTILE CELLS IN THE BOUNDARY TISSUE OF SEMINIFEROUS TUBULES

open access: bronze, 1965
Manabu Kagayama   +3 more
openalex   +2 more sources

Size and shape of transverse tubule openings in frog twitch muscle fibers. [PDF]

open access: bronze, 1975
Clara Franzini‐Armstrong   +2 more
openalex   +1 more source

The effect of elexacaftor–tezacaftor–ivacaftor on liver stiffness in children with cystic fibrosis

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Cystic fibrosis hepato‐biliary involvement (CFHBI) is a common comorbidity in patients with CF and is associated with increased morbidity and mortality. The effect of the new and highly potent CF transmembrane conductance regulator modulator therapy, elexacaftor–tezacaftor–ivacaftor (ETI), on CFHBI, is still unclear.
Stefanie Diemer   +4 more
wiley   +1 more source

Otolaryngologic Side Effects of GLP‐1 Receptor Agonists

open access: yesThe Laryngoscope, EarlyView.
Objectives With the increasing use of GLP‐1 receptor agonist (GLP‐1 RA) drugs for weight loss and diabetes management, concerns have been raised regarding their potential side effects. We aim to assess the frequency of otolaryngologic adverse events (AEs). Study Design Retrospective analysis of national registry.
Faizaan I. Khan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy